Overview
INSM market data
Price History
INSM price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for INSM. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga · Jul 21, 2026, 11:58 AM
BMO Capital Initiates Coverage On Insmed with Outperform Rating, Announces Price Target of $192Benzinga · Jul 21, 2026, 10:14 AM
Insmed Sees Sustained Gains With Inhaled Drug for Stressed Heart FunctioningBenzinga · Jul 16, 2026, 6:32 PM
Insmed Announces 12-Month TPIP OLE Data Demonstrating Sustained Improvement, Mortality Risk Reduction, And No Newly Identified Safety Signals In PAHBenzinga · Jul 16, 2026, 11:03 AM
8-K filing — INSMED Inc (INSM)SEC EDGAR · Jul 16, 2026, 11:00 AM
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $161Benzinga · Jul 15, 2026, 11:46 AM
Guggenheim Reiterates Buy on Insmed, Maintains $207 Price TargetBenzinga · Jul 10, 2026, 12:40 PM
Evercore ISI Group Maintains Outperform on Insmed, Lowers Price Target to $160Benzinga · Jun 22, 2026, 4:25 PM
Why Is Nebius Stock Surging On Tuesday?Benzinga · Jun 16, 2026, 6:10 PM
CoreWeave, Astera Labs, Nebius Group, And Others Added To Nasdaq-100: A 'Big Deal,' Says Jim CramerBenzinga · Jun 12, 2026, 12:50 PM